Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Hyperhidrosis, Maternal exposure during pregnancy, Musculoskeletal stiffness
Clinical narrative: Pregnant at the time of vaccination?: Yes; Right arm stiff and sore; Right arm stiff and sore; dry painful eyes; dry painful eyes; sweats and chills; sweats and chills; headache; tired; sore throat; dizziness (off balance); dizziness (off balance); This is a spontaneous report from a non-contactable consumer or other non hcp (patient). This consumer or other non hcp reported information for mother. This is a mother report. A 37-years-old pregnant female patient received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number ER2613, expiration date unspecified), via an unspecified route of ad-ministration, administered in Arm Right on 13Apr2021 08:45 as DOSE 2, SINGLE for covid-19 immunization (37 year when vaccinated) at public clinic. Previously the patient received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number EN6208, expiration date unspecified), via an unspecified route of administration, administered in Arm Right on 23Mar2021 09:15 as DOSE 1, SINGLE for covid-19 immunization (37 year when vaccinated). The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Medical history included idiopathic intracranial hypertension from an unknown date, epilepsy from an unknown date, psoriatic arthropathy from an unknown date, rheumatoid arthritis from an unknown date, autoimmune thyroiditis from an unknown date, hypertension from an unknown date, food allergy from an unknown date. Concomitant medications included certolizumab pegol (CIMZIA) taken for an unspecified indication, from an unknown start date, hydroxychloroquine sulfate (PLAQUENIL [HYDROXYCHLOROQUINE SUL-FATE]) taken for an unspecified indication, from an unknown start date, levetiracetam (KEPPRA [LE-VETIRACETAM]) taken for an unspecified indication, from an unknown start date, labetalol (LABETALOL) taken for an unspecified indication, from an unknown start date, acetazolamide (DIA-MOX [ACETAZOLAMIDE]) taken for an unspecified indication, from an unknown start date, levothyroxine sodium (SYNTHROID) taken for an unspecified indication, from an unknown start date were not reported. The patient was not diagnosed with COVID-19 prior to the vaccination. On an unknown date, the patient reported that she was pregnant at the time of vaccination. On 13Apr2021 11:00, the patient experienced her right arm to be stiff and sore, followed by dry painful eyes, sweats and chills, patient also had headache. On the same day the patient also felt tired, dizziness and was little off balance. The patient had sore throat. The patient was 30 weeks pregnant at the onset of the events. The mother was due to deliver on 23Jun2021. The patient did not receive any treatment for the events. The out-come of the events was reported as unknown.  No follow-up attempts are possible. No further information is expected.  Amendment: This follow-up report is being submitted to amend previously reported information: event Maternal exposure during pregnancy was recoded to Maternal Exposure During Pregnancy, third trimester. This follow-up report is being submitted to allow appropriate reporting to health authorities.